Načítá se...
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family. Acting in an endocrine fashion, it increases glucose uptake, modulates lipid metabolism, and sensitizes insulin response in metabolically active organs, including the liver and adipose tissue. Emerging evidence shows a stro...
Uloženo v:
| Vydáno v: | Endocrinol Metab (Seoul) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Endocrine Society
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5503858/ https://ncbi.nlm.nih.gov/pubmed/28537053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2017.32.2.145 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|